1. Home
  2. ATER vs TPST Comparison

ATER vs TPST Comparison

Compare ATER & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aterian Inc.

ATER

Aterian Inc.

HOLD

Current Price

$0.41

Market Cap

13.4M

ML Signal

HOLD

Logo Tempest Therapeutics Inc.

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$0.93

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATER
TPST
Founded
2014
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
15.6M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
ATER
TPST
Price
$0.41
$0.93
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
227.4K
123.2K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
55.77
N/A
EPS
N/A
N/A
Revenue
$68,975,000.00
$295,000.00
Revenue This Year
$16.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$0.87
52 Week High
$1.87
$12.22

Technical Indicators

Market Signals
Indicator
ATER
TPST
Relative Strength Index (RSI) 20.13 31.09
Support Level N/A N/A
Resistance Level $0.70 $1.09
Average True Range (ATR) 0.13 0.08
MACD -0.10 0.01
Stochastic Oscillator 0.06 25.59

Price Performance

Historical Comparison
ATER
TPST

About ATER Aterian Inc.

Aterian Inc is a consumer products company that operates through online retail channels, including Amazon, Walmart, Target, as well as its own direct-to-consumer websites. The company develops and manages a portfolio of owned brands, which are either internally incubated or acquired, offering products across multiple categories such as home and kitchen appliances, kitchenware, air quality appliances, health and beauty products, and essential oils. Its primary brands include Squatty Potty, HomeLabs, Mueller Living, PurSteam, Healing Solutions, and Photo Paper Direct. The company generates revenue mainly through the online sale of its consumer products, with substantially all sales derived from the Amazon U.S. marketplace.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.

Share on Social Networks: